Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
melatonin (1 trial)
Attention Deficit Disorder with Hyperactivity (Phase 4)
Disease (Phase 4)
Dyssomnias (Phase 4)
Hyperkinesis (Phase 4)
Parasomnias (Phase 4)
Sleep Wake Disorders (Phase 4)
Trials (1 total)
Trial APIs (1 total)